or Try an Advanced Search...

    Technical Analysis for TYRA - Tyra Biosciences, Inc.

    Grade Last Price % Change Price Change
    F 15.87 -2.10% -0.34
    TYRA closed down 2.1 percent on Wednesday, November 20, 2024, on 69 percent of normal volume.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical TYRA trend table...
    Date Alert Name Type % Chg
    1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    MACD Bullish Signal Line Cross Bullish 0.00%
    Spinning Top Other 0.00%
    Wide Bands Range Expansion 0.00%
    Wide Bands Range Expansion -2.10%
    Oversold Stochastic Weakness -2.10%
    NR7 Range Contraction 2.59%
    Narrow Range Bar Range Contraction 2.59%
    Inside Day Range Contraction 2.59%
    Older End-of-Day Signals for TYRA ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 18 hours ago
    Down 3% about 18 hours ago
    60 Minute Opening Range Breakout about 21 hours ago
    Up 1% about 21 hours ago
    10 DMA Support about 22 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    TYRA Chart by TradingView
    Basic chart:

    Profile

    Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting FGFR2-related cancers, FGFR3-related achondroplasia, REarranged during transfection kinase, and FGFR4-related cancers. Tyra Biosciences, Inc. was incorporated in 2018 and is headquartered in Carlsbad, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Biology Tumor Cell Biology Tyrosine Kinase Receptors Bladder Cancer Preclinical Stage Biopharmaceutical Clusters Of Differentiation Fibroblast Growth Factor Fibroblast Growth Factor Receptor

    Is TYRA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 13 Tyra Biosciences to Present at Upcoming Investor Conferences
    Nov 8 Tyra Biosciences GAAP EPS of -$0.41 beats by $0.06
    Nov 7 Tyra Biosciences Reports Third Quarter 2024 Financial Results and Highlights
    Nov 3 Chief Financial Officer of Tyra Biosciences Alan Fuhrman Buys 284% More Shares
    Oct 28 Tyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Pediatric Achondroplasia (BEACH301)
    Oct 25 Tyra stock plunges 17% amid TYRA-300 study data release
    Oct 24 Tyra Biosciences Reports Interim Clinical Proof-of-Concept Data for TYRA-300, an Investigational Oral FGFR3-Selective Inhibitor, in Phase 1/2 SURF301 Study in Patients with Metastatic Urothelial Cancer (mUC)
    Oct 23 Tyra Biosciences to Host Conference Call on Interim Clinical Data of TYRA-300 from SURF301 Phase 1/2 Study on October 25, 2024, at 8am ET
    Oct 21 Tyra Biosciences: Upcoming FGFR3 Inhibitor Data Is A Major Inflection Point
    Oct 20 Here's Why We're Not Too Worried About Tyra Biosciences' (NASDAQ:TYRA) Cash Burn Situation
    See more TYRA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 29.6
    52 Week Low 10.6004
    Average Volume 371,160
    200-Day Moving Average 19.23
    50-Day Moving Average 21.00
    20-Day Moving Average 17.36
    10-Day Moving Average 16.05
    Average True Range 1.39
    RSI (14) 36.31
    ADX 30.51
    +DI 16.49
    -DI 27.72
    Chandelier Exit (Long, 3 ATRs) 25.42
    Chandelier Exit (Short, 3 ATRs) 19.22
    Upper Bollinger Bands 23.33
    Lower Bollinger Band 11.39
    Percent B (%b) 0.38
    BandWidth 68.80
    MACD Line -1.73
    MACD Signal Line -1.75
    MACD Histogram 0.0197
    Fundamentals Value
    Market Cap 830.71 Million
    Num Shares 52.3 Million
    EPS -1.39
    Price-to-Earnings (P/E) Ratio -11.42
    Price-to-Sales 0.00
    Price-to-Book 4.30
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 17.31
    Resistance 3 (R3) 17.36 16.94 17.07
    Resistance 2 (R2) 16.94 16.57 16.91 16.99
    Resistance 1 (R1) 16.40 16.34 16.19 16.35 16.91
    Pivot Point 15.98 15.98 15.87 15.95 15.98
    Support 1 (S1) 15.44 15.61 15.23 15.39 14.83
    Support 2 (S2) 15.02 15.38 14.99 14.75
    Support 3 (S3) 14.48 15.02 14.67
    Support 4 (S4) 14.43